Artera vs TeleVox (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

The two incumbent patient communication platforms, both with long delivery histories and thin technical disclosure. Artera orchestrates agents across voice, text and web at more than a thousand provider organisations, with named integrations into commercial and federal record systems, the strongest security disclosure in this category and an explicit account of where automation stops and staff take over. TeleVox built its business on automated reminders over decades and now adds a conversational layer on top of that delivery infrastructure, including physical mail, which nobody else here covers. For an organisation already running TeleVox, adding conversation is continuity. For one starting fresh, Artera publishes more of what a governance review will ask for, and TeleVox's substantive privacy material still belongs to a former parent.

The case for Artera
  • Reach and integration are the strongest in this category, with named integrations across commercial and federal record systems and more than a thousand provider organisations.
  • It sells the autonomy gradient explicitly, with staff able to take over at any point, rather than leaving the boundary to be discovered in a pilot.
  • The security disclosure is the best in this category, which matters for a vendor holding patient communication at very large volume.
The case for TeleVox
  • Decades of delivery infrastructure across text, voice, email and physical mail, which is a different asset from a conversational layer.
  • Conversational scope is bounded and stated rather than open ended, covering inquiries, appointment management and routine requests.
  • For an organisation already sending millions of reminders through it, adding conversation is continuity rather than a migration.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Artera and TeleVox are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Artera TeleVox
Primary category Patient Voice Agents Healthcare Administrative Automation
Headquarters Santa Barbara, California Not recorded
Website artera.io televox.com
Attribute Matrix

Side by Side

Axis
A
Artera
T
TeleVox
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Artera

The AI Health Index awards Artera its top capability grade on several axes, including Autonomy and Oversight Model, Security Certifications and Trust Center and EHR and Interoperability Depth. Set against TeleVox, Artera grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

TeleVox

The AI Health Index records no top capability grade for TeleVox on any axis it scores. Set against Artera, TeleVox does not grade higher on any scored axis, though the two are level on HIPAA and BAA Posture. Its thinnest published disclosure sits on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Artera or TeleVox?

The AI Health Index grades Artera higher than TeleVox on every axis that separates them, several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. TeleVox does not grade higher on any scored axis.

Where do Artera and TeleVox differ most?

The widest separation the AI Health Index records between Artera and TeleVox is on Model Supply Chain Disclosure, where Artera grades B and TeleVox grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do Artera and TeleVox grade the same?

The AI Health Index grades Artera and TeleVox the same on HIPAA and BAA Posture. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

What have Artera and TeleVox not disclosed?

At the last review, at least one of Artera and TeleVox published thin or absent detail on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.

Disclosure

TeleVox's most substantive privacy material belongs to a former corporate parent and is roughly a decade old, which is not the same as the current entity's position, so ask for current documents in the current company's name. Neither vendor publishes an architecture description, model detail, validation methodology or accuracy figure, and neither publishes performance across caller populations, which is the fairness question in patient communication. Neither publishes pricing, and volume based charging makes the two hard to compare without a modelled scenario.